📈 Economy · Next Month

Sanofi S.A. (EPA: SAN) beats Q2-2026 adjusted Business EPS consensus of approx. EUR 1.88 per share (July 30, 2026)

Hit ✦ AI-generated prediction Published on 22. July 2026 · Predicted for 30. July 2026 · Based on: Historical Cycle

Probability

67%

Sanofi publishes Q2-2026 results on July 30. Business EPS consensus ~€1.88; revenue consensus ~€11.39B (Chartmill/TipRanks, July 2026). In Q1 2026, Sanofi delivered double-digit sales and Business EPS growth, driven by Dupixent (leading biologic for atopic dermatitis/asthma, quarterly revenue >€4B) and Beyfortus (RSV infant protection, seasonally lower in Q2). Annual guidance: high single-digit sales growth, Business EPS slightly faster than sales. No prediction market found.

Data basis for this prediction

Chartmill / TipRanks: SAN Q2 2026 Business-EPS-Konsens 1,88 EUR, Umsatz-Konsens 11,39 Mrd. EUR (Jul 2026)
Sanofi Pressemitteilung: Q1 2026 – zweistelliges Umsatz- und Business-EPS-Wachstum (23.04.2026)
Sanofi IR: Q2-2026-Ergebnisankündigung für 30. Juli 2026 (sanofi.com)

Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.

Verdict: Hit

Sanofi berichtete am 30. Juli 2026 einen Business-EPS von €2,09 für Q2 2026 – deutlich über dem Konsens von ~€1,88 (Übertreffung um ca. +11%). Der Nettoumsatz lag bei €11,597 Mrd. und übertraf ebenfalls den Konsens von ~€11,39 Mrd. Haupttreiber: Dupixent (+37,6% auf €5,154 Mrd.) und starkes Pharma-Launch-Geschäft (+48,3%). Die Guidance für 2026 wurde daraufhin angehoben (Umsatzwachstum nun ~10% bei KWK). Quelle: Sanofi Pressemitteilung vom 30.07.2026 (globenewswire.com/news-release/2026/07/30/3335767) und Sanofi Investor Relations (sanofi.com/en/investors/financial-results-and-events/financial-results/q2-2026-results).

Related Predictions

📈 Economy ✦ AI

S&P 500 (SPX) closes above 7,500 on Friday, 13 November 2026 (confirmed via NYSE closing price or Bloomberg by 14 November 2026, 10:00 ET)

The S&P 500 dropped 4.36% on 5 November 2026 to 7,353.73 — its steepest one-day fall since April 2025 — triggered by an AI-chip selloff that wiped out the post-midterm rally (4 November: +1.72% to 7,698.80). Closing above 7,500 by 13 November requires a +2.0% recovery over 6 trading sessions. Goldman Sachs, Morgan Stanley and JPMorgan maintain year-end targets of 7,400–8,100; S&P 500 EPS growth consensus for 2026 stands at +14% YoY. Downside risks: elevated Treasury yields, persistent AI capex uncertainty. No specific Polymarket/Kalshi market found for this level.

62%

Next Week · Predicted for 13. Nov 2026

📈 Economy ✦ AI

US Consumer Price Index (headline CPI) for October 2026 exceeds 3.7 percent year-on-year — BLS release November 10, 2026, 8:30 AM ET (confirmed by BLS or Bloomberg by November 10, 2026, 10:00 AM ET)

The BLS releases October 2026 CPI on November 10, 2026 at 8:30 AM ET. Nowflation forecasts 3.82 percent YoY; the Cleveland Fed nowcasting model forecasts 3.74 percent — both clearly above the 3.7 percent threshold. The September 2026 prior reading was exactly 3.7 percent. Rising energy prices (Strait of Hormuz effectively closed since mid-October) and stable core inflation support a further uptick. An existing open platform prediction covers CPI >3.5%; this forecast raises the bar by 20 basis points. A miss would primarily require unexpected weakness in the energy component or food prices.

65%

Next Week · Predicted for 10. Nov 2026

📈 Economy ✦ AI

Gold (XAU/USD Spot) closes above $4,400 per ounce on 31 December 2026 (confirmed by Bloomberg or Kitco by 1 January 2027)

Gold (XAU/USD) rose to $4,134.83 on 5 November 2026 — driven by the Democratic midterm sweep (higher fiscal spending expected) and persistent inflation pressure. Kalshi's Dec 31 settlement market shows ~32% probability for a close above $4,400 and ~43% for above $4,300. Reaching the $4,400 year-end target would require a further ~6.4% gain. Supporting factors: fiscal expansion, geopolitical risks, structurally high central bank demand; UBS forecasts $4,800, JPMorgan $6,000 at year-end. Headwind: hawkish Fed stance (Polymarket: 72.5% for a December rate hike to 4.00–4.25%). Prediction anchors on Kalshi's ~32% for >$4,400.

32%

Next Year · Predicted for 31. Dec 2026